Received Jan 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 934FZ | IM / LA |
Injection site warm and tenderness at injection site 2 weeks post immunization. pt denies systemic adverse effects. no visble s/sx of infection.
n/a
hypercholesterolemia
unknown
NKDA